Global Hog Cholera Vaccine Market Research Report 2023

Hog Cholera Vaccine Market

Hog cholera, is a contagious viral disease of domestic and wild swine. 

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hog Cholera Vaccine market research.

The hog cholera vaccine market is primarily driven by the need to control and prevent the spread of the highly contagious and economically devastating hog cholera virus (classical swine fever). Vaccination plays a critical role in protecting swine populations and the pig farming industry from this deadly viral disease, which can result in high mortality rates and trade restrictions. The global demand for pork products also fuels the need to ensure the health and well-being of swine herds, making the hog cholera vaccine essential in maintaining a stable and profitable pork supply chain. However, the market also faces challenges, such as the emergence of new strains of the hog cholera virus, which may require the development of updated or novel vaccine formulations. Ensuring the efficacy and safety of vaccines against these evolving strains is crucial to maintain disease control measures. Additionally, the cost of vaccination programs and the accessibility of vaccines to pig farmers, especially in developing regions, can pose obstacles to widespread adoption. Addressing these challenges through continued research and development, international cooperation in disease monitoring, and government support in implementing effective vaccination programs will be essential to drive the growth of the hog cholera vaccine market and protect the swine industry from this significant threat.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hog Cholera Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Hog Cholera Vaccine Market Report

1.1 Product Overview and Scope of Hog Cholera Vaccine

1.2 Hog Cholera Vaccine Segment by Type

1.2.1 Global Hog Cholera Vaccine Market Value Comparison by Type (2023-2029)

1.2.2 Tissue Culture Origin

1.2.3 Cell Line Origin

1.3 Hog Cholera Vaccine Segment by Application

1.3.1 Global Hog Cholera Vaccine Market Value by Application: (2023-2029)

1.3.2 Government Tender

1.3.3 Market Sales

1.4 Global Hog Cholera Vaccine Market Size Estimates and Forecasts

1.4.1 Global Hog Cholera Vaccine Revenue 2018-2029

1.4.2 Global Hog Cholera Vaccine Sales 2018-2029

1.4.3 Global Hog Cholera Vaccine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Hog Cholera Vaccine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Hog Cholera Vaccine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Hog Cholera Vaccine Average Price by Manufacturers (2018-2023)

2.4 Global Hog Cholera Vaccine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Hog Cholera Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Hog Cholera Vaccine, Product Type & Application

2.7 Hog Cholera Vaccine Market Competitive Situation and Trends

2.7.1 Hog Cholera Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Hog Cholera Vaccine Players Market Share by Revenue

2.7.3 Global Hog Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Hog Cholera Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Hog Cholera Vaccine Global Hog Cholera Vaccine Sales by Region: 2018-2029

3.2.1 Global Hog Cholera Vaccine Sales by Region: 2018-2023

3.2.2 Global Hog Cholera Vaccine Sales by Region: 2024-2029

3.3 Global Hog Cholera Vaccine Global Hog Cholera Vaccine Revenue by Region: 2018-2029

3.3.1 Global Hog Cholera Vaccine Revenue by Region: 2018-2023

3.3.2 Global Hog Cholera Vaccine Revenue by Region: 2024-2029

3.4 North America Hog Cholera Vaccine Market Facts & Figures by Country

3.4.1 North America Hog Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Hog Cholera Vaccine Sales by Country (2018-2029)

3.4.3 North America Hog Cholera Vaccine Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Hog Cholera Vaccine Market Facts & Figures by Country

3.5.1 Europe Hog Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Hog Cholera Vaccine Sales by Country (2018-2029)

3.5.3 Europe Hog Cholera Vaccine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Hog Cholera Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Hog Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Hog Cholera Vaccine Sales by Country (2018-2029)

3.6.3 Asia Pacific Hog Cholera Vaccine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Hog Cholera Vaccine Market Facts & Figures by Country

3.7.1 Latin America Hog Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Hog Cholera Vaccine Sales by Country (2018-2029)

3.7.3 Latin America Hog Cholera Vaccine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Hog Cholera Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Hog Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Hog Cholera Vaccine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Hog Cholera Vaccine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Hog Cholera Vaccine Sales by Type (2018-2029)

4.1.1 Global Hog Cholera Vaccine Sales by Type (2018-2023)

4.1.2 Global Hog Cholera Vaccine Sales by Type (2024-2029)

4.1.3 Global Hog Cholera Vaccine Sales Market Share by Type (2018-2029)

4.2 Global Hog Cholera Vaccine Revenue by Type (2018-2029)

4.2.1 Global Hog Cholera Vaccine Revenue by Type (2018-2023)

4.2.2 Global Hog Cholera Vaccine Revenue by Type (2024-2029)

4.2.3 Global Hog Cholera Vaccine Revenue Market Share by Type (2018-2029)

4.3 Global Hog Cholera Vaccine Price by Type (2018-2029)

5.1 Global Hog Cholera Vaccine Sales by Application (2018-2029)

5.1.1 Global Hog Cholera Vaccine Sales by Application (2018-2023)

5.1.2 Global Hog Cholera Vaccine Sales by Application (2024-2029)

5.1.3 Global Hog Cholera Vaccine Sales Market Share by Application (2018-2029)

5.2 Global Hog Cholera Vaccine Revenue by Application (2018-2029)

5.2.1 Global Hog Cholera Vaccine Revenue by Application (2018-2023)

5.2.2 Global Hog Cholera Vaccine Revenue by Application (2024-2029)

5.2.3 Global Hog Cholera Vaccine Revenue Market Share by Application (2018-2029)

5.3 Global Hog Cholera Vaccine Price by Application (2018-2029)

6.1 WINSUN

6.1.1 WINSUN Corporation Information

6.1.2 WINSUN Description and Business Overview

6.1.3 WINSUN Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 WINSUN Hog Cholera Vaccine Product Portfolio

6.1.5 WINSUN Recent Developments/Updates

6.2 Boehringer Ingelheim

6.2.1 Boehringer Ingelheim Corporation Information

6.2.2 Boehringer Ingelheim Description and Business Overview

6.2.3 Boehringer Ingelheim Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Boehringer Ingelheim Hog Cholera Vaccine Product Portfolio

6.2.5 Boehringer Ingelheim Recent Developments/Updates

6.3 CAHIC

6.3.1 CAHIC Corporation Information

6.3.2 CAHIC Description and Business Overview

6.3.3 CAHIC Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 CAHIC Hog Cholera Vaccine Product Portfolio

6.3.5 CAHIC Recent Developments/Updates

6.4 Chopper Biology

6.4.1 Chopper Biology Corporation Information

6.4.2 Chopper Biology Description and Business Overview

6.4.3 Chopper Biology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Chopper Biology Hog Cholera Vaccine Product Portfolio

6.4.5 Chopper Biology Recent Developments/Updates

6.5 MSD Animal Health (Merck)

6.5.1 MSD Animal Health (Merck) Corporation Information

6.5.2 MSD Animal Health (Merck) Description and Business Overview

6.5.3 MSD Animal Health (Merck) Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 MSD Animal Health (Merck) Hog Cholera Vaccine Product Portfolio

6.5.5 MSD Animal Health (Merck) Recent Developments/Updates

6.6 ChengDu Tecbond

6.6.1 ChengDu Tecbond Corporation Information

6.6.2 ChengDu Tecbond Description and Business Overview

6.6.3 ChengDu Tecbond Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 ChengDu Tecbond Hog Cholera Vaccine Product Portfolio

6.6.5 ChengDu Tecbond Recent Developments/Updates

6.7 Ceva

6.6.1 Ceva Corporation Information

6.6.2 Ceva Description and Business Overview

6.6.3 Ceva Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Ceva Hog Cholera Vaccine Product Portfolio

6.7.5 Ceva Recent Developments/Updates

6.8 Harbin Veterinary Research Institute

6.8.1 Harbin Veterinary Research Institute Corporation Information

6.8.2 Harbin Veterinary Research Institute Description and Business Overview

6.8.3 Harbin Veterinary Research Institute Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Harbin Veterinary Research Institute Hog Cholera Vaccine Product Portfolio

6.8.5 Harbin Veterinary Research Institute Recent Developments/Updates

6.9 Qilu Animal Health Products Factory

6.9.1 Qilu Animal Health Products Factory Corporation Information

6.9.2 Qilu Animal Health Products Factory Description and Business Overview

6.9.3 Qilu Animal Health Products Factory Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Qilu Animal Health Products Factory Hog Cholera Vaccine Product Portfolio

6.9.5 Qilu Animal Health Products Factory Recent Developments/Updates

6.10 Ringpu Biology

6.10.1 Ringpu Biology Corporation Information

6.10.2 Ringpu Biology Description and Business Overview

6.10.3 Ringpu Biology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Ringpu Biology Hog Cholera Vaccine Product Portfolio

6.10.5 Ringpu Biology Recent Developments/Updates

6.11 DHN

6.11.1 DHN Corporation Information

6.11.2 DHN Hog Cholera Vaccine Description and Business Overview

6.11.3 DHN Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.11.4 DHN Hog Cholera Vaccine Product Portfolio

6.11.5 DHN Recent Developments/Updates

6.12 CAVAC

6.12.1 CAVAC Corporation Information

6.12.2 CAVAC Hog Cholera Vaccine Description and Business Overview

6.12.3 CAVAC Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.12.4 CAVAC Hog Cholera Vaccine Product Portfolio

6.12.5 CAVAC Recent Developments/Updates

6.13 Komipharm

6.13.1 Komipharm Corporation Information

6.13.2 Komipharm Hog Cholera Vaccine Description and Business Overview

6.13.3 Komipharm Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Komipharm Hog Cholera Vaccine Product Portfolio

6.13.5 Komipharm Recent Developments/Updates

6.14 Agrovet

6.14.1 Agrovet Corporation Information

6.14.2 Agrovet Hog Cholera Vaccine Description and Business Overview

6.14.3 Agrovet Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Agrovet Hog Cholera Vaccine Product Portfolio

6.14.5 Agrovet Recent Developments/Updates

6.15 Bioveta

6.15.1 Bioveta Corporation Information

6.15.2 Bioveta Hog Cholera Vaccine Description and Business Overview

6.15.3 Bioveta Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Bioveta Hog Cholera Vaccine Product Portfolio

6.15.5 Bioveta Recent Developments/Updates

6.16 Jinyu Bio-Technology

6.16.1 Jinyu Bio-Technology Corporation Information

6.16.2 Jinyu Bio-Technology Hog Cholera Vaccine Description and Business Overview

6.16.3 Jinyu Bio-Technology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.16.4 Jinyu Bio-Technology Hog Cholera Vaccine Product Portfolio

6.16.5 Jinyu Bio-Technology Recent Developments/Updates

6.17 Institutul Pasteur

6.17.1 Institutul Pasteur Corporation Information

6.17.2 Institutul Pasteur Hog Cholera Vaccine Description and Business Overview

6.17.3 Institutul Pasteur Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.17.4 Institutul Pasteur Hog Cholera Vaccine Product Portfolio

6.17.5 Institutul Pasteur Recent Developments/Updates

6.18 MVP

6.18.1 MVP Corporation Information

6.18.2 MVP Hog Cholera Vaccine Description and Business Overview

6.18.3 MVP Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.18.4 MVP Hog Cholera Vaccine Product Portfolio

6.18.5 MVP Recent Developments/Updates

6.19 Tecon

6.19.1 Tecon Corporation Information

6.19.2 Tecon Hog Cholera Vaccine Description and Business Overview

6.19.3 Tecon Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.19.4 Tecon Hog Cholera Vaccine Product Portfolio

6.19.5 Tecon Recent Developments/Updates

7.1 Hog Cholera Vaccine Industry Chain Analysis

7.2 Hog Cholera Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Hog Cholera Vaccine Production Mode & Process

7.4 Hog Cholera Vaccine Sales and Marketing

7.4.1 Hog Cholera Vaccine Sales Channels

7.4.2 Hog Cholera Vaccine Distributors

7.5 Hog Cholera Vaccine Customers

8.1 Hog Cholera Vaccine Industry Trends

8.2 Hog Cholera Vaccine Market Drivers

8.3 Hog Cholera Vaccine Market Challenges

8.4 Hog Cholera Vaccine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Hog Cholera Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Hog Cholera Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Hog Cholera Vaccine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Hog Cholera Vaccine Sales (M Units) of Key Manufacturers (2018-2023)

    Table 5. Global Hog Cholera Vaccine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Hog Cholera Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Hog Cholera Vaccine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Hog Cholera Vaccine Average Price (US$/K Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Hog Cholera Vaccine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Hog Cholera Vaccine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Hog Cholera Vaccine, Product Type & Application

    Table 12. Global Key Manufacturers of Hog Cholera Vaccine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Hog Cholera Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hog Cholera Vaccine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Hog Cholera Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Hog Cholera Vaccine Sales by Region (2018-2023) & (M Units)

    Table 18. Global Hog Cholera Vaccine Sales Market Share by Region (2018-2023)

    Table 19. Global Hog Cholera Vaccine Sales by Region (2024-2029) & (M Units)

    Table 20. Global Hog Cholera Vaccine Sales Market Share by Region (2024-2029)

    Table 21. Global Hog Cholera Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Hog Cholera Vaccine Revenue Market Share by Region (2018-2023)

    Table 23. Global Hog Cholera Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Hog Cholera Vaccine Revenue Market Share by Region (2024-2029)

    Table 25. North America Hog Cholera Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Hog Cholera Vaccine Sales by Country (2018-2023) & (M Units)

    Table 27. North America Hog Cholera Vaccine Sales by Country (2024-2029) & (M Units)

    Table 28. North America Hog Cholera Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Hog Cholera Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Hog Cholera Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Hog Cholera Vaccine Sales by Country (2018-2023) & (M Units)

    Table 32. Europe Hog Cholera Vaccine Sales by Country (2024-2029) & (M Units)

    Table 33. Europe Hog Cholera Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Hog Cholera Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Hog Cholera Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Hog Cholera Vaccine Sales by Region (2018-2023) & (M Units)

    Table 37. Asia Pacific Hog Cholera Vaccine Sales by Region (2024-2029) & (M Units)

    Table 38. Asia Pacific Hog Cholera Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Hog Cholera Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Hog Cholera Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Hog Cholera Vaccine Sales by Country (2018-2023) & (M Units)

    Table 42. Latin America Hog Cholera Vaccine Sales by Country (2024-2029) & (M Units)

    Table 43. Latin America Hog Cholera Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Hog Cholera Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Hog Cholera Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Hog Cholera Vaccine Sales by Country (2018-2023) & (M Units)

    Table 47. Middle East & Africa Hog Cholera Vaccine Sales by Country (2024-2029) & (M Units)

    Table 48. Middle East & Africa Hog Cholera Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Hog Cholera Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Hog Cholera Vaccine Sales (M Units) by Type (2018-2023)

    Table 51. Global Hog Cholera Vaccine Sales (M Units) by Type (2024-2029)

    Table 52. Global Hog Cholera Vaccine Sales Market Share by Type (2018-2023)

    Table 53. Global Hog Cholera Vaccine Sales Market Share by Type (2024-2029)

    Table 54. Global Hog Cholera Vaccine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Hog Cholera Vaccine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Hog Cholera Vaccine Revenue Market Share by Type (2018-2023)

    Table 57. Global Hog Cholera Vaccine Revenue Market Share by Type (2024-2029)

    Table 58. Global Hog Cholera Vaccine Price (US$/K Unit) by Type (2018-2023)

    Table 59. Global Hog Cholera Vaccine Price (US$/K Unit) by Type (2024-2029)

    Table 60. Global Hog Cholera Vaccine Sales (M Units) by Application (2018-2023)

    Table 61. Global Hog Cholera Vaccine Sales (M Units) by Application (2024-2029)

    Table 62. Global Hog Cholera Vaccine Sales Market Share by Application (2018-2023)

    Table 63. Global Hog Cholera Vaccine Sales Market Share by Application (2024-2029)

    Table 64. Global Hog Cholera Vaccine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Hog Cholera Vaccine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Hog Cholera Vaccine Revenue Market Share by Application (2018-2023)

    Table 67. Global Hog Cholera Vaccine Revenue Market Share by Application (2024-2029)

    Table 68. Global Hog Cholera Vaccine Price (US$/K Unit) by Application (2018-2023)

    Table 69. Global Hog Cholera Vaccine Price (US$/K Unit) by Application (2024-2029)

    Table 70. WINSUN Corporation Information

    Table 71. WINSUN Description and Business Overview

    Table 72. WINSUN Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 73. WINSUN Hog Cholera Vaccine Product

    Table 74. WINSUN Recent Developments/Updates

    Table 75. Boehringer Ingelheim Corporation Information

    Table 76. Boehringer Ingelheim Description and Business Overview

    Table 77. Boehringer Ingelheim Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 78. Boehringer Ingelheim Hog Cholera Vaccine Product

    Table 79. Boehringer Ingelheim Recent Developments/Updates

    Table 80. CAHIC Corporation Information

    Table 81. CAHIC Description and Business Overview

    Table 82. CAHIC Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 83. CAHIC Hog Cholera Vaccine Product

    Table 84. CAHIC Recent Developments/Updates

    Table 85. Chopper Biology Corporation Information

    Table 86. Chopper Biology Description and Business Overview

    Table 87. Chopper Biology Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 88. Chopper Biology Hog Cholera Vaccine Product

    Table 89. Chopper Biology Recent Developments/Updates

    Table 90. MSD Animal Health (Merck) Corporation Information

    Table 91. MSD Animal Health (Merck) Description and Business Overview

    Table 92. MSD Animal Health (Merck) Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 93. MSD Animal Health (Merck) Hog Cholera Vaccine Product

    Table 94. MSD Animal Health (Merck) Recent Developments/Updates

    Table 95. ChengDu Tecbond Corporation Information

    Table 96. ChengDu Tecbond Description and Business Overview

    Table 97. ChengDu Tecbond Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 98. ChengDu Tecbond Hog Cholera Vaccine Product

    Table 99. ChengDu Tecbond Recent Developments/Updates

    Table 100. Ceva Corporation Information

    Table 101. Ceva Description and Business Overview

    Table 102. Ceva Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 103. Ceva Hog Cholera Vaccine Product

    Table 104. Ceva Recent Developments/Updates

    Table 105. Harbin Veterinary Research Institute Corporation Information

    Table 106. Harbin Veterinary Research Institute Description and Business Overview

    Table 107. Harbin Veterinary Research Institute Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 108. Harbin Veterinary Research Institute Hog Cholera Vaccine Product

    Table 109. Harbin Veterinary Research Institute Recent Developments/Updates

    Table 110. Qilu Animal Health Products Factory Corporation Information

    Table 111. Qilu Animal Health Products Factory Description and Business Overview

    Table 112. Qilu Animal Health Products Factory Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 113. Qilu Animal Health Products Factory Hog Cholera Vaccine Product

    Table 114. Qilu Animal Health Products Factory Recent Developments/Updates

    Table 115. Ringpu Biology Corporation Information

    Table 116. Ringpu Biology Description and Business Overview

    Table 117. Ringpu Biology Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 118. Ringpu Biology Hog Cholera Vaccine Product

    Table 119. Ringpu Biology Recent Developments/Updates

    Table 120. DHN Corporation Information

    Table 121. DHN Description and Business Overview

    Table 122. DHN Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 123. DHN Hog Cholera Vaccine Product

    Table 124. DHN Recent Developments/Updates

    Table 125. CAVAC Corporation Information

    Table 126. CAVAC Description and Business Overview

    Table 127. CAVAC Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 128. CAVAC Hog Cholera Vaccine Product

    Table 129. CAVAC Recent Developments/Updates

    Table 130. Komipharm Corporation Information

    Table 131. Komipharm Description and Business Overview

    Table 132. Komipharm Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 133. Komipharm Hog Cholera Vaccine Product

    Table 134. Komipharm Recent Developments/Updates

    Table 135. Agrovet Corporation Information

    Table 136. Agrovet Description and Business Overview

    Table 137. Agrovet Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 138. Agrovet Hog Cholera Vaccine Product

    Table 139. Agrovet Recent Developments/Updates

    Table 140. Bioveta Corporation Information

    Table 141. Bioveta Description and Business Overview

    Table 142. Bioveta Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 143. Bioveta Hog Cholera Vaccine Product

    Table 144. Bioveta Recent Developments/Updates

    Table 145. Jinyu Bio-Technology Corporation Information

    Table 146. Jinyu Bio-Technology Description and Business Overview

    Table 147. Jinyu Bio-Technology Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 148. Jinyu Bio-Technology Hog Cholera Vaccine Product

    Table 149. Jinyu Bio-Technology Recent Developments/Updates

    Table 150. Institutul Pasteur Corporation Information

    Table 151. Institutul Pasteur Description and Business Overview

    Table 152. Institutul Pasteur Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 153. Institutul Pasteur Hog Cholera Vaccine Product

    Table 154. Institutul Pasteur Recent Developments/Updates

    Table 155. MVP Corporation Information

    Table 156. MVP Description and Business Overview

    Table 157. MVP Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 158. MVP Hog Cholera Vaccine Product

    Table 159. MVP Recent Developments/Updates

    Table 160. Tecon Corporation Information

    Table 161. Tecon Description and Business Overview

    Table 162. Tecon Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)

    Table 163. Tecon Hog Cholera Vaccine Product

    Table 164. Tecon Recent Developments/Updates

    Table 165. Key Raw Materials Lists

    Table 166. Raw Materials Key Suppliers Lists

    Table 167. Hog Cholera Vaccine Distributors List

    Table 168. Hog Cholera Vaccine Customers List

    Table 169. Hog Cholera Vaccine Market Trends

    Table 170. Hog Cholera Vaccine Market Drivers

    Table 171. Hog Cholera Vaccine Market Challenges

    Table 172. Hog Cholera Vaccine Market Restraints

    Table 173. Research Programs/Design for This Report

    Table 174. Key Data Information from Secondary Sources

    Table 175. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Hog Cholera Vaccine

    Figure 2. Global Hog Cholera Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Hog Cholera Vaccine Market Share by Type in 2022 & 2029

    Figure 4. Tissue Culture Origin Product Picture

    Figure 5. Cell Line Origin Product Picture

    Figure 6. Global Hog Cholera Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Hog Cholera Vaccine Market Share by Application in 2022 & 2029

    Figure 8. Government Tender

    Figure 9. Market Sales

    Figure 10. Global Hog Cholera Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 11. Global Hog Cholera Vaccine Market Size (2018-2029) & (US$ Million)

    Figure 12. Global Hog Cholera Vaccine Sales (2018-2029) & (M Units)

    Figure 13. Global Hog Cholera Vaccine Average Price (US$/K Unit) & (2018-2029)

    Figure 14. Hog Cholera Vaccine Report Years Considered

    Figure 15. Hog Cholera Vaccine Sales Share by Manufacturers in 2022

    Figure 16. Global Hog Cholera Vaccine Revenue Share by Manufacturers in 2022

    Figure 17. The Global 5 and 10 Largest Hog Cholera Vaccine Players: Market Share by Revenue in 2022

    Figure 18. Hog Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 19. Global Hog Cholera Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 20. North America Hog Cholera Vaccine Sales Market Share by Country (2018-2029)

    Figure 21. North America Hog Cholera Vaccine Revenue Market Share by Country (2018-2029)

    Figure 22. United States Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 23. Canada Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Europe Hog Cholera Vaccine Sales Market Share by Country (2018-2029)

    Figure 25. Europe Hog Cholera Vaccine Revenue Market Share by Country (2018-2029)

    Figure 26. Germany Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. France Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. U.K. Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Italy Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Russia Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Asia Pacific Hog Cholera Vaccine Sales Market Share by Region (2018-2029)

    Figure 32. Asia Pacific Hog Cholera Vaccine Revenue Market Share by Region (2018-2029)

    Figure 33. China Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Japan Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. South Korea Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. India Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Australia Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. China Taiwan Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Latin America Hog Cholera Vaccine Sales Market Share by Country (2018-2029)

    Figure 41. Latin America Hog Cholera Vaccine Revenue Market Share by Country (2018-2029)

    Figure 42. Mexico Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Brazil Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Argentina Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Colombia Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Hog Cholera Vaccine Sales Market Share by Country (2018-2029)

    Figure 47. Middle East & Africa Hog Cholera Vaccine Revenue Market Share by Country (2018-2029)

    Figure 48. Turkey Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. UAE Hog Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Global Sales Market Share of Hog Cholera Vaccine by Type (2018-2029)

    Figure 52. Global Revenue Market Share of Hog Cholera Vaccine by Type (2018-2029)

    Figure 53. Global Hog Cholera Vaccine Price (US$/K Unit) by Type (2018-2029)

    Figure 54. Global Sales Market Share of Hog Cholera Vaccine by Application (2018-2029)

    Figure 55. Global Revenue Market Share of Hog Cholera Vaccine by Application (2018-2029)

    Figure 56. Global Hog Cholera Vaccine Price (US$/K Unit) by Application (2018-2029)

    Figure 57. Hog Cholera Vaccine Value Chain

    Figure 58. Hog Cholera Vaccine Production Process

    Figure 59. Channels of Distribution (Direct Vs Distribution)

    Figure 60. Distributors Profiles

    Figure 61. Bottom-up and Top-down Approaches for This Report

    Figure 62. Data Triangulation

    Figure 63. Key Executives Interviewed